Related Experiment Video
Updated: Apr 17, 2026

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity
Published on: January 31, 2025
Melanoma of the lower extremities: foot site is an independent risk factor for clinical outcome
Martina Sanlorenzo1, Simona Osella-Abate1, Simone Ribero1,2
1Section of Dermatology, Department of Medical Sciences, University of Turin, Turin, Italy.
Background:
Despite the better prognosis of melanomas localized on lower extremities, some studies have suggested that melanomas on the foot are related to a poorer survival and should be considered separately.
Objective:
To review our case series of cutaneous melanomas on the lower extremities and to analyze the clinicopathological association, time course, types of progression, and survival differences.
Methods:
We included 1671 patients (stage 0-II) with a cutaneous melanoma on the lower extremities (subungual melanomas were excluded). Of these, 327 were localized on the foot. Multivariate analyses were performed to evaluate disease-specific survival and disease-free interval.
Results:
Distribution of known prognostic factors and patterns of progression of foot and leg melanoma differ across genders. The foot site was confirmed as a negative independent prognostic factor on disease-specific survival and disease-free interval.
Conclusion:
Foot melanoma could represent a particular subgroup, which could require specific management in the future.
Related Concept Videos
Pulse Assessment Sites
Diabetic Foot Ulcer
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

